Diagnosis, impact, and management of focal hyperhidrosis: treatment review including botulinum toxin therapy.

AboutSkin Dermatology and DermSurgery, Englewood, CO 80113, USA.
Facial Plastic Surgery Clinics of North America (Impact Factor: 1.18). 03/2007; 15(1):17-30, v-vi. DOI: 10.1016/j.fsc.2006.10.002
Source: PubMed

ABSTRACT Idiopathic localized hyperhidrosis, called for hyperhidrosis, affects almost 3% of the US population. The most frequent anatomic sites of involvement include the axillae, palms, soles, and face. For those affected, this condition can be extremely socially debilitating and interfere with work activities. Until recently, frequently ineffective topical regimens or problematic surgical procedures have been the treatments of choice. Since 1996, intracutaneous injections of botulinum toxin have been used as a minimally invasive treatment for this condition with numerous studies documenting safety, efficacy, and extremely high levels of patient satisfaction. Botulinum toxin type A (Botox) was approved by the US Food and Drug Administration in 2004 for the treatment of axillary hyperhidrosis.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Suction curettage is a dermatologic surgery technique for the treatment of axillary hyperhidrosis, which is becoming more popular.
    Anais brasileiros de dermatologia 12/2014; 89(6):940-54. DOI:10.1590/abd1806-4841.20142873
  • [Show abstract] [Hide abstract]
    ABSTRACT: Botulinum toxin is a safe and effective treatment option for axillary hyperhidrosis. Although its pathophysiology is not clear and somewhat controversial, the beneficial effect of neuromodulators in inhibiting localized sweating temporarily is well known. Before the procedure, correct identification of the affected area is mandatory to avoid wastage of drug and neglect of target areas, and to enhance efficacy, as the hyperhidrotic location may not match the hairy axillary region. Utilization of this medication, such as dilution and injection techniques, depends on medical experience and may have some variations, including methods to make the procedure as painless as possible.
    Dermatologic Clinics 10/2014; DOI:10.1016/j.det.2014.06.013 · 1.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hyperhidrosis, characterized by excess sweat production, affects children and adults. Primary focal hyperhidrosis affects any anatomic region with sweat appendages present. Primary hyperhidrosis has traditionally been considered a problem for adults, but approximately 1.6% of adolescents and 0.6% of prepubertal children are affected. Psychological and social development and well-being are often affected, leading to profound emotional and social distress. Quality of life can be improved by early diagnosis and therapy; however, underdiagnosis and lack of knowledge regarding therapeutic options has hindered optimization of therapy in the pediatric population. This article reviews the treatment options for hyperhidrosis with a focus on the pediatric population.
    Dermatologic Clinics 10/2014; DOI:10.1016/j.det.2014.06.005 · 1.43 Impact Factor